Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure, cloud-based platform for tackling pressing global health issues. With just a few drops of blood from a finger prick, the system generates lab-accurate results on the spot and data is reported in real time. The test menu includes up to 23 key biomarkers for screening and managing chronic diseases, such as diabetes and heart disease (e.g., HbA1c, Lipid Profile, eGFR). The HealthTab also has capabilities for bacterial and viral tests, such as strep and COVID-19. The HealthTab platform transforms pharmacies into community point-of-care diagnostic centers.


TSXV:AVCR - Post by User

Bullboard Posts
Comment by TheKing1021on Apr 28, 2016 10:57am
140 Views
Post# 24820199

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dream Job

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dream JobExactly Sly. Vancpharm should be sitting a lot higher than it is right now though IMO.

Personally, I would just like to get to the bottom of why the investor relations team choose to do nothing. In the beginning I understood a little more, but now even the tardiness in regards to publishing financials in a news release or on their website is mind boggling to me.

If management is instructing them to not do anything that is one thing, but if they are simply just being lazy and or focusing their attention on some of their other projects then that's something that needs to be addressed at the AGM.

A couple weeks ago I went to click on the OTC products on their main webpage and a blank error page just comes up as nothing is even properly linked. Little stuff like that just makes a company seem unprofessional. 

Anyway, most of us are aware of the website issues. I just find it a little crazy how we are currently trading lower than we were pre q1 release.
Bullboard Posts